252Cf Plasma desorption with time-of-flight mass spectrometry (TOF-PDMS) has been applied to comparative studies of the interactions of steroid glycosides (SGs) of the spirostan series with amino acids. SGs can interact with amino acids to form heteroclusters of the type [SG + aminoacid + H](+) and
252Cf plasma desorption mass spectrometric study of the inclusion complexes of cyclodextrins with coumarins
β Scribed by Anna V. Gubskaya; Sergey A. Aksyonov; Alexey N. Kalinkevich; Yury V. Lisnyak; Vladimir P. Chuev; Vadim D. Chivanov
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 135 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0951-4198
No coin nor oath required. For personal study only.
β¦ Synopsis
252 Cf plasma desorption mass spectrometry was used to investigate the formation of complexes of 7-amino-4-methylcoumarins with Ξ²and Ξ³-cyclodextrins. The individual substances and their co-ground mixtures were analyzed by plasma desorption ionization. In the negative-ion mass spectra of cyclodextrins highly characteristic fragmentation peaks were detected, and a scheme for the fragmentation pathway is proposed. The inclusion complex of 7-amino-4-methylcoumarin with Ξ²-cyclodextrin was obtained, and the peak corresponding to the complex was observed in the PDMS spectra. Various modes of inclusion of the coumarins into cyclodextrins, that can result in stable complex formation, are discussed in the light of molecular mechanics calculations. In spite of the possibility in principle of the inclusion of 7-amino-4-methylcoumarin into Ξ²-cyclodextrin, and of 7-N,N-diethyl-amino-4-methylcoumarin into Ξ³-cyclodextrin, the complexes of these compounds appear to be insufficiently stable and they decomposed under the desorption/ionization conditions.
π SIMILAR VOLUMES
The formation of complexes and the mode of binding to macrocyclic host molecules (a-and bcyclodextrins, CDs) of the nootropic drug CI-844 (3-phenoxypyridine sulphate, Warner-Lambert/Parke-Davis) were studied using NMR techniques (T-ROESY) complemented by molecular dynamics (MD) protocols which allow